Filing Details
- Accession Number:
- 0001179110-16-029281
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-02 17:25:50
- Reporting Period:
- 2016-08-31
- Filing Date:
- 2016-09-02
- Accepted Time:
- 2016-09-02 17:25:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1204787 | Clive Meanwell | 8 Sylvan Way Parsippany NJ 07054 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-31 | 378 | $28.08 | 339,168 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2016-09-01 | 1,377 | $28.60 | 340,545 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-01 | 1,377 | $40.00 | 339,168 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right-to-buy) | Disposition | 2016-09-01 | 1,377 | $0.00 | 1,377 | $28.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 68,623 | 2017-02-16 | No | 4 | M | Direct |
Footnotes
- Acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning March 1, 2016 and ending August 31, 2016. In accordance with the terms of the ESPP, these shares were purchased based on 85% of the fair market value closing price of the issuer's common stock on March 1, 2016.
- Sales were effected pursuant to a Rule 10b-5 program adopted by Dr. Meanwell.
- This option vested in forty-eight equal installments beginning on March 16, 2007.
- Not applicable.
Billionaire Hedge Funds
